Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03191656
Other study ID # 1701
Secondary ID
Status Recruiting
Phase
First received
Last updated
Start date July 12, 2017
Est. completion date July 31, 2028

Study information

Verified date February 2024
Source Corvia Medical
Contact Jan Komtebedde, DVM
Phone 978-654-6113
Email jkomtebedde@corviamedical.com
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

This is a post market trial to be conducted at sites in Germany. The device has CE approval in the EU. The purpose of this observational registry is to collect post market data in consecutive patients treated with the IASD System II, to further evaluate efficacy, safety and quality of life outcomes as a new treatment for patients with heart failure in a "real world" practice setting.


Recruitment information / eligibility

Status Recruiting
Enrollment 500
Est. completion date July 31, 2028
Est. primary completion date July 31, 2026
Accepts healthy volunteers No
Gender All
Age group 40 Years and older
Eligibility This is a post market registry so no criteria requirements (only recommendations).

Study Design


Related Conditions & MeSH terms


Intervention

Device:
IASD Implant
Implantation of the IASD device using trans-septal puncture and the IASD system

Locations

Country Name City State
Germany Herzzentrum der Kerckhoff-Klinik Bad Nauheim
Germany Herz- und Diabeteszentrum Nordrhein-Westfalen Klinik für Kardiologie Bad Oeynhausen
Germany Segeberger Kliniken GmbH Bad Segeberg
Germany Unfallkrankenhaus Berlin Berlin
Germany Klinikum Chemnitz gGmbH Chemnitz
Germany Klinikum Lippe GmbH Detmold
Germany Herzzentrum Dresden GmbH Dresden
Germany Universitätsklinikum Düsseldorf Klinik für Kardiologie, Pneumologie u. Angiologie Düsseldorf
Germany Elisabeth-Krankenhaus Essen Essen
Germany Universitätsklinikum Gießen Giessen
Germany Universitätsklinikum Göttingen Göttingen
Germany Universitäts Klinikum Halle Halle
Germany Klinikum am Plattenwald Bad Friedrichshall Heilbronn
Germany Klinikum Karlsburg Karlsburg
Germany Klinik für Innere Medizin III mit den Schwerpunkten Kardiologie, Angiologie und internistische Kiel
Germany Herzzentrum der Universität zu Köln Köln
Germany Klinikum Sankt Georg Leipzig
Germany Universitätsklinikum Schleswig-Holstein Lübeck
Germany Universitätsklinikum Munster Münster
Germany Niels-Stensen-Kliniken - Marienhospital Osnabrück
Germany St Vincenz-Kranenhaus Paderborn
Germany Herz-Kreislauf-Zentrum Rotenburg Rotenburg
Germany Helios Kliniken Schwerin Schwerin
Germany Universitätsklinik Ulm-Keßler Ülm
Germany Evangelisches Krankenhaus Paul Gerhardt Stift - Unfallstation Wittenberg
Germany Heinrich Braun Klinikum Zwickaü
Switzerland Bürgelspital Solothurn Solothurn

Sponsors (1)

Lead Sponsor Collaborator
Corvia Medical

Countries where clinical trial is conducted

Germany,  Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary Serious Adverse Events Device and or procedure related serious adverse cardiac events 30 days
Primary New York Heart Classification Improvement in NYHA Classification 12 months
Primary Quality of Life Improvement (KCCQ score) Improvement in KCCQ score 12 months
Primary Quality of Life Improvement (EQ5D) Improvement in EQ5D score 12 months
See also
  Status Clinical Trial Phase
Recruiting NCT05650307 - CV Imaging of Metabolic Interventions
Recruiting NCT05196659 - Collaborative Quality Improvement (C-QIP) Study N/A
Recruiting NCT05654272 - Development of CIRC Technologies
Active, not recruiting NCT05896904 - Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction N/A
Completed NCT05077293 - Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
Recruiting NCT05631275 - The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
Enrolling by invitation NCT05564572 - Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology N/A
Enrolling by invitation NCT05009706 - Self-care in Older Frail Persons With Heart Failure Intervention N/A
Recruiting NCT04177199 - What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
Terminated NCT03615469 - Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY) N/A
Recruiting NCT06340048 - Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure Phase 1/Phase 2
Recruiting NCT05679713 - Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
Completed NCT04254328 - The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure N/A
Completed NCT03549169 - Decision Making for the Management the Symptoms in Adults of Heart Failure N/A
Recruiting NCT05572814 - Transform: Teaching, Technology, and Teams N/A
Enrolling by invitation NCT05538611 - Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
Recruiting NCT04262830 - Cancer Therapy Effects on the Heart
Completed NCT06026683 - Conduction System Stimulation to Avoid Left Ventricle Dysfunction N/A
Withdrawn NCT03091998 - Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support Phase 1
Recruiting NCT05564689 - Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy